Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AYTU BIOPHARMA, INC | Financial_Report.xls |
| EX-31.1 - EX-31.1 - AYTU BIOPHARMA, INC | d922847dex311.htm |
| EX-31.2 - EX-31.2 - AYTU BIOPHARMA, INC | d922847dex312.htm |
| 10-Q - FORM 10-Q - AYTU BIOPHARMA, INC | d922847d10q.htm |
Exhibit 32.1
ROSEWIND CORPORATION
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended March 31, 2015 (the “Report”) by Rosewind Corporation (the “Company”), each of the undersigned hereby certifies that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: May 19, 2015 | /s/ Joshua R. Disbrow | |||||
| Joshua R. Disbrow | ||||||
| Chief Executive Officer | ||||||
| Dated: May 19, 2015 | /s/ Gregory A. Gould | |||||
| Gregory A. Gould | ||||||
| Chief Financial Officer | ||||||